• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov7
Lemaitre Vascular released FY2025 Q3 earnings on November 6 After-Market EST, actual revenue USD 61.05 M (forecast USD 62.17 M), actual EPS USD 0.7527 (forecast USD 0.5654)
00:00
Lemaitre Vascular released FY2025 9 Months Earnings on November 6 After-Market EST, with actual revenue of USD 185.15 M and EPS of USD 1.83
00:00
Oct30
Lemaitre Vascular to release FY2025 Q3 earnings on November 6 After-Market EST, forecast revenue USD 62.18 M, EPS USD 0.566
00:25
Oct15
Petusky Rates Lemaitre Vascular as a Moderate Buy
12:02
Aug7
Barrington Research Upgrades LeMaitre Vascular Stock Rating
12:02
Aug6
Lemaitre Vascular released FY2025 Semi-Annual Earnings on August 6 After-Market (EST), actual revenue USD 124.1 M, actual EPS USD 1.08
23:00

Schedules & Filings

Schedules
Filings
Dec4
Distribution Plan(EST)

Cash dividend 0.2 USD

Nov20
Distribution Plan(EST)

Cash dividend 0.2 USD

Distribution Plan(EST)

Cash dividend 0.2 USD

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
BBGI
16.690
+312.10%
+12.640
SRV.RT
0.0900
+111.76%
+0.048
BEAT
1.550
+92.43%
+0.745
ENVB
10.330
+74.49%
+4.410
BDRX
6.720
+65.11%
+2.650
ASPC
16.810
+60.40%
+6.330
IRBT
5.240
+48.44%
+1.710
CGTL
0.9727
+47.40%
+0.313
MIGI
6.700
+45.65%
+2.100
PLAB
37.350
+45.39%
+11.660
View More